Closing Figures: Resmed Inc (RMD)’s Negative Finish at 231.43, Down -1.70

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $235.44 in the prior trading day, Resmed Inc (NYSE: RMD) closed at $231.43, down -1.70%. In other words, the price has decreased by -$1.70 from its previous closing price. On the day, 1.08 million shares were traded. RMD stock price reached its highest trading level at $236.89 during the session, while it also had its lowest trading level at $231.18.

Ratios:

Our goal is to gain a better understanding of RMD by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 79.68 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.10. For the most recent quarter (mrq), Quick Ratio is recorded 1.91 and its Current Ratio is at 2.92. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.16.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on September 24, 2024, initiated with a Outperform rating and assigned the stock a target price of $280.

On September 18, 2024, Wolfe Research Downgraded its rating to Underperform which previously was Peer Perform but kept the price unchanged to $180.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 12 ’24 when De Witte Jan sold 796 shares for $248.81 per share. The transaction valued at 198,053 led to the insider holds 6,723 shares of the business.

Farrell Michael J. sold 14,683 shares of RMD for $3,615,821 on Nov 07 ’24. The Chief Executive Officer now owns 464,254 shares after completing the transaction at $246.26 per share. On Nov 08 ’24, another insider, Sandercock Brett, who serves as the Chief Financial Officer of the company, sold 1,000 shares for $249.00 each. As a result, the insider received 249,000 and left with 94,864 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RMD now has a Market Capitalization of 33972998144 and an Enterprise Value of 34380603392. As of this moment, Resmed’s Price-to-Earnings (P/E) ratio for their current fiscal year is 30.68, and their Forward P/E ratio for the next fiscal year is 22.35. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.80. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.07 while its Price-to-Book (P/B) ratio in mrq is 6.54. Its current Enterprise Value per Revenue stands at 7.151 whereas that against EBITDA is 21.064.

Stock Price History:

Over the past 52 weeks, RMD has reached a high of $260.49, while it has fallen to a 52-week low of $144.29. The 50-Day Moving Average of the stock is -4.78%, while the 200-Day Moving Average is calculated to be 8.87%.

Shares Statistics:

The stock has traded on average 1.02M shares per day over the past 3-months and 971530 shares per day over the last 10 days, according to various share statistics. A total of 146.90M shares are outstanding, with a floating share count of 145.62M. Insiders hold about 0.80% of the company’s shares, while institutions hold 60.51% stake in the company. Shares short for RMD as of 1730332800 were 7893566 with a Short Ratio of 7.75, compared to 1727654400 on 8570196. Therefore, it implies a Short% of Shares Outstanding of 7893566 and a Short% of Float of 6.1899999999999995.

Dividends & Splits

In the trailing 12 months, RMD’s forward annual dividend rate was 1.97, compared to 2.02 this year. Against a Trailing Annual Dividend Yield of 0.008367312The stock’s 5-year Average Dividend Yield is 0.84.

Most Popular